Zai Lab (ZLAB) Free Cash Flow (2018 - 2026)
Zai Lab (ZLAB) posted Free Cash Flow of -$13.1 million for Q1 2026, up 50.91% sequentially from -$26.7 million in Q4 2025, and up 79.27% YoY from -$7.3 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Free Cash Flow (2018 - 2026) Analysis & Trends
Zai Lab has reported Free Cash Flow for 9 years, with the latest figure at -$13.1 million in Q1 2026.
- Quarterly Free Cash Flow rose 79.27% year-over-year to -$13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108.8 million (up 43.55% YoY) and the FY2025 annual result came in at -$158.9 million, up 27.95% from the prior year.
- Free Cash Flow rose to -$13.1 million in Q1 2026 per ZLAB's latest filing, from -$26.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$13.1 million in Q1 2026 and troughed at -$133.0 million in Q3 2022.
- A 5-year average of -$58.2 million and a median of -$57.0 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow jumped 86.69% in 2023, then slumped 285.55% in 2024.
- Over 5 years, Free Cash Flow stood at -$113.7 million in 2022, then surged by 86.69% to -$15.1 million in 2023, then plunged by 285.55% to -$58.4 million in 2024, then soared by 54.26% to -$26.7 million in 2025, then soared by 50.91% to -$13.1 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$13.1 million, -$26.7 million, and -$35.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | -64.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.72 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -26.70 Mn |
| Sep 30, 2025 | -35.05 Mn |
| Jun 30, 2025 | -33.91 Mn |
| Mar 31, 2025 | -63.23 Mn |
| Dec 31, 2024 | -58.37 Mn |
| Sep 30, 2024 | -28.16 Mn |
| Jun 30, 2024 | -42.91 Mn |
| Mar 31, 2024 | -91.08 Mn |
| Dec 31, 2023 | -15.14 Mn |
| Sep 30, 2023 | -57.03 Mn |
| Jun 30, 2023 | -60.42 Mn |
| Mar 31, 2023 | -72.80 Mn |
| Dec 31, 2022 | -113.71 Mn |
| Sep 30, 2022 | -133.01 Mn |
| Jun 30, 2022 | -48.65 Mn |
| Mar 31, 2022 | -96.87 Mn |
| Dec 31, 2021 | -159.37 Mn |
| Sep 30, 2021 | -167.16 Mn |